BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced its third quarter 2009 financial results.
BioSante incurred a net loss of approximately $6.4 million or ($0.21) per share for the quarter ended September 30, 2009, compared to a net loss of $6.6 million or ($0.24) per share for the same period in 2008. This decrease in net loss was [...]

Continue reading " BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results "